Iran-Israel Conflict Escalates: Strikes on Nuclear Facilities and Civilian Targets Reportedईरान-इज़राइल संघर्ष: इज़राइल ने अराक और नतान्ज़ परमाणु ठिकानों पर किए हमले, ईरान ने इज़राइल की मेडिकल बिल्डिंग को बनाया निशाना

19 जून, 2025
On the seventh day of its military campaign, Israel launched airstrikes on Iranian nuclear sites, including a reactor near Arak and a facility near Natanz, which it described as a nuclear weapons development center. Reports also confirmed that a heavy-water facility near Khondab, previously known as the Arak reactor, was targeted.

In retaliation, Iran fired missiles that struck a medical facility in Israel, damaging nearby residential buildings. Emergency responders called it a “direct hit,” though no casualties have been officially confirmed yet.

Meanwhile, about 100 Indian students were safely evacuated from Iran and arrived in Delhi on Thursday morning as part of Operation Sindhu.

According to AP, Israel’s air operations have resulted in the deaths of senior Iranian generals and nuclear scientists. A US-based Iranian human rights group reported that at least 639 people have died in Iran so far, including 263 civilians, with over 1,300 injured.

On the Israeli side, Iran has launched around 400 missiles and deployed hundreds of drones. These attacks have killed at least 24 people and injured many others.

US President Donald Trump has remained non-committal about American involvement, saying, “I may do it. I may not do it,” while noting that Iranian officials have shown interest in dialogue, albeit “too late.”

Israeli Prime Minister Netanyahu confirmed that the operation is gradually dismantling Iran’s nuclear and missile capabilities, and expressed gratitude to Trump for his support.

In response, Iran’s Supreme Leader Ayatollah Khamenei rejected any notion of surrender, warning the US that any military intervention would result in severe and lasting consequences.

More From Author

Delhi woman goes missing, two bodies found, but no closure: A murder case that collapsed after years

Leave a Reply

Your email address will not be published. Required fields are marked *